| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/09/2008 | WO2007103528A3 Compressible resilient granules and formulations prepared therefrom |
| 10/09/2008 | WO2007100881A3 Antimicrobial medical devices |
| 10/09/2008 | WO2006074117A3 Silver/water, silver gels and silver-based compositions; and methods for making and using the same |
| 10/09/2008 | WO2006030301A8 Cilostazol- containing pharmaceutical composition based on particles of less than 50 micrometers |
| 10/09/2008 | US20080249511 In Situ Blood Vessel and Aneurysm Treatment |
| 10/09/2008 | US20080249510 Membrane-based fluid control in microfluidic devices |
| 10/09/2008 | US20080249497 Osmotically-driven fluid dispenser |
| 10/09/2008 | US20080249185 Alleviating acute alcohol intoxication/side effects of a hangover by administering, for example, 2,3-dimercapto-1-propanol; food additives/supplements; animal feed; oxidation resistance; immunostimulants; demetallization; shelf life cosmetology; dermatology; food additives/supplements; feeds; drugs |
| 10/09/2008 | US20080249147 Emulsion-Stabilized Preparation |
| 10/09/2008 | US20080249143 New formulations and use thereof |
| 10/09/2008 | US20080249076 slow release over an extended period of time and markedly increased bioavailability; significantly reduces food effect and may reduce side effects; dissolved in a solid vehicle or carrier and is especially suitable for oral solid dosage forms |
| 10/09/2008 | US20080249069 Method of treatment using bisphosphonic acid |
| 10/09/2008 | US20080249044 Nucleic acid external skin formulation |
| 10/09/2008 | US20080249041 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 10/09/2008 | US20080248998 Glyceryl stearate or glyceryl palmitostearate to mask bad flavor of drugs; anti-bacterial, antifungal, metronidazole, anti-parasitic, nivaquine, antiviral, anti-cancer, analgesics, non-steroidal anti-inflammatories, anti-tussives, psychotropic, steroids, anti-histamines, anti-allergic agents |
| 10/09/2008 | US20080248991 Chitosan Containing Solution |
| 10/09/2008 | US20080248126 preparation of drug-polymer (or oligomer) conjugates; nanoprecipitation |
| 10/09/2008 | US20080248125 biodegradable; vinyl methyl ether and maleic anhydride (PVM/MA) copolymer; excellent bioadhesion, size and zeta potential characteristics |
| 10/09/2008 | US20080248124 Process for producing pharmaceutical composition |
| 10/09/2008 | US20080248123 zolpidem, phenytoin; controlled release; surface modifier selected from anionic surfactants, cationic surfactants, zwitterionic surfactants, nonionic surfactants, surface active biological modifiers; hydroxypropyl methyl cellulose, hydrogenated oil or polyvinylpyrrolidone as rate controlling polymer |
| 10/09/2008 | US20080248122 preparing microencapsules by forming a microparticle containing active agent, forming a monolayer including charged compound (ionomers, polyelectrolytes) on the microparticle, thus forming a surface-modified microparticle, encapsulating the surface-modified microparticles; sustained release |
| 10/09/2008 | US20080248121 Multiple emulsion containing a tensioning agent |
| 10/09/2008 | US20080248120 Aerosol Composition and Method |
| 10/09/2008 | US20080248119 Production method of drug containing composite particle |
| 10/09/2008 | US20080248118 Antioxidant superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase hemeoxygenase, acetyl salicyclic acid, mannitol, captopril, Arg, or pyruvate; vitamins(lycopene, lutein, xeaxanthine, Vitamin A, carotene); administered via carotid artery or juguar vein |
| 10/09/2008 | US20080248117 Production of Solid Solutions Based on Poorly-Soluble Active Substances by a Short-Term Heating and Rapid Drying |
| 10/09/2008 | US20080248116 a mixture of bone morphogenic proteins and transformation growth factors, used for treating bone disorders such as osteoporosis |
| 10/09/2008 | US20080248115 Combinations of statins and anti-obesity agent |
| 10/09/2008 | US20080248114 an improved 16-hour cumulative dissolution of dihydropyridine drug such as isradipine; a drug layer, an osmotic layer, and an outer coating includes an opening, surrounding the drug layer and osmotic layer; dosage form (tablets); 2% N,N-dimethyl dodecylamine N-oxide (LDAO) or equivalent solvent |
| 10/09/2008 | US20080248113 An opioid selected from oxymorphone, hydromorphone, morphine, oxycodone hydrochloride with potential for abuse and a synthetic or natural polymer (polyoxyethylene glycol, polyethylene, polypropylene, PVC, polycarbonate, polystyrene, polyacrylates; delayed release; nonadduactive |
| 10/09/2008 | US20080248112 Use of ranolazine for the treatment of coronary microvascular diseases |
| 10/09/2008 | US20080248111 Fluoxetine hydrochloride complexed with a divinylbenzene crosslinked polymethacrylic acid; microcrystalline celllulose and colloidal silica as hdrophilic adsorbent; core is coated by a gastrosoluble polymer (alkyl methacrylate/aminoalkyl methacrylate copolymers); masks unpleasant taste of the drug |
| 10/09/2008 | US20080248110 Pharmaceutical Compositions Useful in the Treatment of Pain |
| 10/09/2008 | US20080248109 succinic acid particles or any salts and (ii) hydroxypropyl methyl cellulose phthalate an enteric-coated proton pump inhibitor (PPI) omeprazole; succinic acid particles are released in the stomach in an amount sufficient to reduce gastric acid secretion in conjunction with the PPI; sustained release |
| 10/09/2008 | US20080248108 Multilayered polyelectrolyte-based capsules for cell encapsulation and delivery of therapeutic compositions |
| 10/09/2008 | US20080248107 Controlled Release Formulation |
| 10/09/2008 | US20080248105 Polymorphic forms of 6-11 bicyclic ketolide derivatives |
| 10/09/2008 | US20080248104 Composition and method for reducing inflammation |
| 10/09/2008 | US20080248103 Melatonin-based composition for improved sleep |
| 10/09/2008 | US20080248102 Rapidly Dissolving Pharmaceutical Compositions Comprising Pullulan |
| 10/09/2008 | US20080248101 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 10/09/2008 | US20080248100 Magnesium compositions and uses thereof |
| 10/09/2008 | US20080248099 using insulin for making medicine to treat Alzheimer's disease, brain atrophy associated with diabetes, Parkinson's disease, Huntington's Disease, senile dementia, multiple sclerosis, dementia associated with Acquired Immunodeficiency Syndrome (AIDS), Pick's Disease, stroke, trauma; tolbutamide |
| 10/09/2008 | US20080248098 Polysaccharide Microparticles Containing Biological Agents: Their Preparation and Applications |
| 10/09/2008 | US20080248097 Polymeric micelles for combination drug delivery |
| 10/09/2008 | US20080248096 Delivering, via small particle aerosol, aqueous dispersions of anti-cancer drugs in liposomes or lipid complexes to respiratory tract of an individual in need of such treatment |
| 10/09/2008 | US20080248095 Delivering, via small particle aerosol, aqueous dispersions of anti-cancer drugs in liposomes or lipid complexes to respiratory tract of an individual in need of such treatment |
| 10/09/2008 | US20080248094 Vaccine adjuvant properties of lipsomes formed at elevated temperatures from the polar chloroform extractable lipids from mycobacterium bovis |
| 10/09/2008 | US20080248093 pH sensitive prodrugs of 2,6-diisopropylphenol |
| 10/09/2008 | US20080248092 Formulations of Water Insoluble or Poorly Water Soluble Drugs in Lipidated Glycosaminoglycan Particles and Their Use for Diagnostic and Therapy |
| 10/09/2008 | US20080248091 Charge Gradient Inhibition of Trypanosoma Cruzi and Other Parasite's Invasive Action |
| 10/09/2008 | US20080248090 NaCl in matrix of silicone, polymer, ceramic, fabric; solid, gel or liquid form; concentrations range from hypotonic to hypertonic; therapeutic agent of dental anesthesia; bacteristats, bacteriocides; anti-pyretic, anti-inflammatory; tooth-strengthening solutions, calcium fluoride |
| 10/09/2008 | US20080248089 wasabi extract of 4-pentenyl isothiocyanate, 5-hexenyl isothiocyanate, 3-butenyl isothiocyanate, 3-methylthiopropyl isothiocyanate; delivered by chewing gum, confectionary product; sensate, potentiator; oral care agents, antibacterial activities, promotion of saliva secretion |
| 10/09/2008 | US20080248088 Decontaminant edible product, methods of production and uses thereof |
| 10/09/2008 | US20080248085 Method of tissue vascularization |
| 10/09/2008 | US20080248077 Anastrozole continuously released from polylactide or poly(lactide-co-glycolide) co-polymer implant over 10 day period in aqueous physiological environment; drug incorporated in microparticle formulations and monolithic implant formulations; breast cancer |
| 10/09/2008 | US20080248074 Treatment for Topical Use in Alleviating or Inhibiting Joint Pain or Muscle Pain or Musculoskeletal Pain in a Mammal |
| 10/09/2008 | US20080248070 pharmaceutical composition including therapeutically effective amounts of at least one HMG-CoA reductase inhibitor present as a dyhydroxyacid salt and at least one additional therapeutic agent |
| 10/09/2008 | US20080248069 Dosage Forms of Active Ingredients Containing Hydroxystilbene for Treating Menopausal Complaints |
| 10/09/2008 | US20080248018 Recombinant human arginase functioning as arginine depleting agent in treatment of cell proliferative disorders |
| 10/09/2008 | US20080248017 Multicompartment drug delivery system for use in treatment of menopausal symptoms and benign ovarian secretory disorder; contraceptive |
| 10/09/2008 | US20080247965 Metering valve and pressurized solution aerosol comprising bronchodilator, hydrofluorocarbon propellant, and cosolvent within container having inorganic coating |
| 10/09/2008 | US20080247964 Substituted azaspiro derivatives |
| 10/09/2008 | US20080247963 Quinuclidine Compounds Having Quaternary Ammonium Group, Its Preparation Method and Use as Blocking Agents of Acetylcholine |
| 10/09/2008 | US20080247962 Pharmaceutical Compositions Comprising Higher Primary Aliphatic Alcohols and Hmg Coa Reductase Inhibitor and Process of Preparation Thereof |
| 10/09/2008 | US20080247961 Nasally administrable compositions of zolpidem and methods of use |
| 10/09/2008 | US20080247960 Foaming Tropical Compositions |
| 10/09/2008 | US20080247959 Form of administration secured against misuse |
| 10/09/2008 | US20080247957 Administering injectable, echogenic nanocapsule and/or microcapsule comprising drug, targeting moiety, or both; biodegradation |
| 10/09/2008 | US20080247943 Emulsion containing high boiling fluorocarbon; particles coated with lipid, surfactant |
| 10/09/2008 | US20080247625 Method and System for Leading Macromolecule Substances into Living Target Cells |
| 10/09/2008 | DE102007016527A1 Chemisch aktivierbare Kapsel für die Durchgangsprüfung und Behandlung des Darm-Trakts Chemically activated capsule for continuity testing and treatment of the intestinal tract |
| 10/09/2008 | CA2702305A1 Cancer cell targeting using nanoparticles |
| 10/09/2008 | CA2683217A1 Compositions for nasal delivery |
| 10/09/2008 | CA2682670A1 A method of producing fast dissolving tablets |
| 10/09/2008 | CA2682493A1 Targeting agent for cancer cell or cancer-associated fibroblast |
| 10/09/2008 | CA2682376A1 Transpulmonary liposome for controlling drug arrival |
| 10/09/2008 | CA2681712A1 Tamibarotene capsule preparation |
| 10/09/2008 | CA2681708A1 Valsartan tablet formulations |
| 10/09/2008 | CA2681565A1 Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery |
| 10/09/2008 | CA2681077A1 Packaged film dosage unit containing a complexate |
| 10/09/2008 | CA2680536A1 Oral disintegrating tablet |
| 10/08/2008 | EP1978068A2 Adhesive Structures for Attachment to Skin |
| 10/08/2008 | EP1977764A1 Formulation of adenovirus for gene therapy |
| 10/08/2008 | EP1977763A1 Antibody-containing stabilizing preparation |
| 10/08/2008 | EP1977757A2 Use of Pelargonium in combination with Plantago for the preparation of a medicament for the prevention/treatment of oral inflammation or pharyngitis |
| 10/08/2008 | EP1977740A1 Composition comprising formoterol and a glucocorticosteroid |
| 10/08/2008 | EP1977739A1 Nanoparticulate composition of chitosan and chondroitin sulfate |
| 10/08/2008 | EP1977738A1 Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 10/08/2008 | EP1977737A1 Flow assessment apparatus and method for quantitatively assessing the flow properties of particulate material |
| 10/08/2008 | EP1977736A1 Oral pulsed dose drug delivery system |
| 10/08/2008 | EP1977735A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 10/08/2008 | EP1977734A1 A method of producing fast dissolving tablets |
| 10/08/2008 | EP1976956A2 Silicone adhesive for adhesion to wet surfaces |
| 10/08/2008 | EP1976797A2 Phyllosilicate formulations for the controlled release of active substances |
| 10/08/2008 | EP1976610A2 Thimerosal removal device |
| 10/08/2008 | EP1976562A1 Water-soluble films comprising low-viscosity alginates |
| 10/08/2008 | EP1976560A2 Thermoreversible oil-in-water emulsion |
| 10/08/2008 | EP1976551A2 Compositions comprising polycation-complexed protein crystals and methods of treatment using them |
| 10/08/2008 | EP1976544A2 Method of using guava extract and composition including guava extract |